What is the main business of Prophase?

The main business activity of Prophase focuses on computer programming activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 10, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Różana 2, 02-548 Warszawa.

What is the share capital?

The share capital of the company is PLN 30,000 (approx. $8,104).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $80,482 in 2024, which is a decrease of 30.3% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $5,592, meaning the company decreased its profit by 55.9%.

What is the largest operating cost?

The largest operating cost category falls under materials and energy. This category amounted to $9,271 in 2024, representing 12% of all operating expenses.

Prophasesp. z o.o.

Computer programming activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-09-10

Share capital

30,000.00 PLN

Activity description

Prophase is an independent Polish company supporting clinical trials for CROs and pharmaceutical companies. Its services include feasibility studies and site selection, regulatory and contract consulting, Phase I–IV trial monitoring, staff recruitment, patient travel expense administration, and study document archiving.

Registered address

ul. Różana 2/57, 02-548 Warszawa, Poland

Website

prophase.eu

Electronic delivery address

AE:PL-50481-92085-CFWRG-25

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 649 days for 2023).

2025not filed
202425/04/2026
202325/04/2026
202229/08/2023
202131/01/2023
202030/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 80.48kMedianUSD 120.81kAverageUSD 1.77m

Net profit

This companyUSD 5.59kMedianUSD 2.93kAverageUSD 25.50k

Operating costs

This companyUSD 74.34kMedianUSD 112.91kAverageUSD 1.69m

Assets

This companyUSD 33.45kMedianUSD 79.64kAverageUSD 1.14m

Industry

Authorized Representatives

Jakub Kasnowski – President of the Management Board

Manner of representation

The company is represented by the President of the Management Board acting independently, or by two members of the management board acting jointly.

Ownership

Owner	Shares	Share value	Stake
Andrzej Michał Karpage 53	100	$2,701.24	33.3333%
Jakub Kasnowskiage 39	100	$2,701.24	33.3333%
Bartosz Andrzej Lisowskiage 42	100	$2,701.24	33.3333%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2018-10-11.

mBank
78 1140 2004 0000 3702 7800 9540

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Phogissp. z o.o.	$224,896.66	phogis.pl
BD Labssp. z o.o.	$153,337.34	bd-labs.pl
Crmium Polandsp. z o.o.	$152,832.33	crmium.com
Simple-Implesp. z o.o.	$118,492.17	simple-imple.pl
DC Softwaresp. z o.o.	$84,121.27	dcsoftware.pl
Centralny Ośrodek Informacji Gospodarczychsp. z o.o.	$80,383.68	coig.com.pl
28dni.Plsp. z o.o.	$69,527.08	28dni.pl
PrognovaP.S.A.	$49,369.83	prognova.pl
Probesp. z o.o.	$40,394.62	getprobe.io
Actn3 Bioinformaticssp. z o.o.	$34,254.75	actn3.pl

FAQ

Last updated: 2026-07-13